MEDPLUS HEALTH SERVICES Financial Statement Analysis
|
||
|
The Revenues of MEDPLUS HEALTH SERVICES have increased by 23.42% YoY .
The Earnings Per Share (EPS) of MEDPLUS HEALTH SERVICES has increased by 129.20 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
MEDPLUS HEALTH SERVICES Last 5 Annual Financial Results
[BOM: 543427|NSE : MEDPLUS]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹5,625 Cr | ₹4,558 Cr | ₹3,779 Cr | ₹3,069 Cr | ₹2,871 Cr |
| Expenses | ₹5,254 Cr | ₹4,276 Cr | ₹3,490 Cr | ₹2,840 Cr | ₹2,737 Cr |
| Operating Profit (Excl OI) | ₹371 Cr | ₹281 Cr | ₹289 Cr | ₹229 Cr | ₹134 Cr |
| Other Income | ₹40 Cr | ₹46 Cr | ₹31 Cr | ₹22 Cr | ₹17 Cr |
| Interest | ₹114 Cr | ₹99 Cr | ₹83 Cr | ₹67 Cr | ₹47 Cr |
| Depreciation | ₹224 Cr | ₹182 Cr | ₹119 Cr | ₹88 Cr | ₹75 Cr |
| Profit Before Tax | ₹73 Cr | ₹47 Cr | ₹118 Cr | ₹95 Cr | ₹29 Cr |
| Profit After Tax | ₹66 Cr | ₹50 Cr | ₹95 Cr | ₹63 Cr | ₹1.79 Cr |
| Consolidated Net Profit | ₹65 Cr | ₹50 Cr | ₹96 Cr | ₹64 Cr | ₹1.79 Cr |
| Earnings Per Share (Rs) | ₹12.56 | ₹5.48 | ₹4.17 | ₹8.03 | ₹1,425.40 |
| PAT Margin (%) | 2.41 | 1.15 | 1.08 | 2.47 | 2.01 |
| ROE(%) | 9.21 | 4.36 | 3.50 | 9.07 | 10.51 |
| ROCE(%) | 18.22 | 12.19 | 9.56 | 16.56 | 21.69 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.10 | 0.20 |
Key Financials |
||
| Market Cap | : | ₹ 9,360.6 Cr |
| Revenue (TTM) | : | ₹ 6,293.0 Cr |
| Net Profit(TTM) | : | ₹ 195.0 Cr |
| EPS (TTM) | : | ₹ 16.3 |
| P/E (TTM) | : | 48.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| MEDPLUS HEALTH SERVICES | 2.2% | 1.5% | 15.3% |
| SUN PHARMACEUTICAL INDUSTRIES | 3.5% | 6.2% | -4.2% |
| DIVIS LABORATORIES | -2.7% | -0.7% | 11% |
| CIPLA | 1.2% | -1.4% | -4.1% |
| TORRENT PHARMACEUTICALS | 0.6% | 9.1% | 19.7% |
| DR REDDYS LABORATORIES | 3.9% | 0.6% | -3.7% |
| MANKIND PHARMA | 1.4% | -6.9% | -15.2% |
| ZYDUS LIFESCIENCES | -0.3% | -3.6% | -2.5% |
| LUPIN | 3.4% | 6.1% | -2.4% |
MEDPLUS HEALTH SERVICES Revenues
[BOM: 543427|NSE : MEDPLUS]
| Y-o-Y | 23.42 % |
| 5 Yr CAGR | 18.31 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,625 Cr | 23.42 | |
| Mar2024 | ₹4,558 Cr | 20.59 | |
| Mar2023 | ₹3,779 Cr | 23.13 | |
| Mar2022 | ₹3,069 Cr | 6.92 | |
| Mar2021 | ₹2,871 Cr | - | |
MEDPLUS HEALTH SERVICES Operating Profit
[BOM: 543427|NSE : MEDPLUS]
| Y-o-Y | 31.96 % |
| 5 Yr CAGR | 29.10 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹371 Cr | 31.96 | |
| Mar2024 | ₹281 Cr | -2.60 | |
| Mar2023 | ₹289 Cr | 26.03 | |
| Mar2022 | ₹229 Cr | 71.47 | |
| Mar2021 | ₹134 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 6.97 % |
| 5 Yr CAGR | 9.09 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 6.6% | 6.97 | |
| Mar2024 | 6.17% | -19.24 | |
| Mar2023 | 7.64% | 2.28 | |
| Mar2022 | 7.47% | 60.30 | |
| Mar2021 | 4.66% | - | |
MEDPLUS HEALTH SERVICES Profit After Tax
[BOM: 543427|NSE : MEDPLUS]
| Y-o-Y | 31.57 % |
| 5 Yr CAGR | 145.79 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹65 Cr | 31.57 | |
| Mar2024 | ₹50 Cr | -48.06 | |
| Mar2023 | ₹96 Cr | 50.02 | |
| Mar2022 | ₹64 Cr | 3,459.53 | |
| Mar2021 | ₹1.79 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 109.57 % |
| 5 Yr CAGR | 4.64 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 2.41 % | 109.57 | |
| Mar2024 | 1.15 % | 6.48 | |
| Mar2023 | 1.08 % | -56.28 | |
| Mar2022 | 2.47 % | 22.89 | |
| Mar2021 | 2.01 % | - | |
MEDPLUS HEALTH SERVICES Earnings Per Share (EPS)
[BOM: 543427|NSE : MEDPLUS]
| Y-o-Y | 129.20 % |
| 5 Yr CAGR | -69.36 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 | 129.20 | |
| Mar2024 | ₹5.48 | 31.41 | |
| Mar2023 | ₹4.17 | -48.07 | |
| Mar2022 | ₹8.03 | -99.44 | |
| Mar2021 | ₹1,425 | - | |
MEDPLUS HEALTH SERVICES Return on Capital Employed (ROCE)
[BOM: 543427|NSE : MEDPLUS]
| Y-o-Y | 49.47 % |
| 5 Yr CAGR | -4.26 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 18.22% | 49.47 | |
| Mar2024 | 12.19% | 27.51 | |
| Mar2023 | 9.56% | -42.27 | |
| Mar2022 | 16.56% | -23.65 | |
| Mar2021 | 21.69% | - | |
MEDPLUS HEALTH SERVICES Share Price vs Sensex
| Current Share Price | : | ₹781.4 |
| Current MarketCap | : | ₹ 9,360.6 Cr |
| Updated EOD on | : | Nov 14,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDPLUS HEALTH SERVICES | 2.2% |
1.5% |
15.3% |
| SENSEX | 1.6% |
2.7% |
6.3% |
MEDPLUS HEALTH SERVICES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
| BSE 500 | 1.3% | 2.2% | 4.1% |
| BSE CONSUMER DISCRETIONARY & SERVICES | 1% | 0.5% | 1.2% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY TOTAL MARKET | 1.3% | 2.3% | 4.1% |
| NIFTY MIDSMALL HEALTHCARE | 0.6% | -0.4% | 3.2% |
| NIFTY MICROCAP 250 | 0.1% | 0.7% | -6.5% |
You may also like the below Video Courses
FAQ about MEDPLUS HEALTH SERVICES Financials
How the annual revenues of MEDPLUS HEALTH SERVICES have changed ?
The Revenues of MEDPLUS HEALTH SERVICES have increased by 23.42% YoY .
How the Earnings per Share (EPS) of MEDPLUS HEALTH SERVICES have changed?
The Earnings Per Share (EPS) of MEDPLUS HEALTH SERVICES has increased by 129.20 % YoY .
Check out Intrinsic Value of Peers of MEDPLUS HEALTH SERVICES
Compare Stock Analytics of Peers of MEDPLUS HEALTH SERVICES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
